Andrew J. Conrad is an American geneticist who was a co-founder at Verily, a life sciences division of Alphabet Inc.[1] As its chief executive officer, Conrad has recruited a multidisciplinary team of chemists, doctors, engineers, behavioral scientists and data scientists to research health and disease.

[3] With the money earned from the sale of NGI, Conrad built a vacation home on the Lānaʻi island of Hawaii.

[3][11] As its chief scientific advisor, Conrad attracted prominent scientists and companies to NCRC to develop products focused on agriculture, food, nutrition, and health.

[15][16] In June 2013 Murdock started the process to take the Dole Food Company private and appointed Conrad at the head of a four-person special committee of independent directors to approve a deal.

[21] In January 2023, Stephen Gillett became the new CEO of Verily,[22] while Conrad shifted roles to become the executive chairman amid a corporate restructuring.

[23] In February 2024, Conrad joined S32, a venture capital firm founded by Bill Maris, as a General Partner.